RAPP

AS OF

Dec 24 closing price

Price

$30.93

Change

+$0.31 (+1.01%)

Capitalization

1.47B

82 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

RAPP

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Rapport Therapeutics (RAPP) Ownership - Who owns Rapport Therapeutics?

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

RAPP

Capitalization

1.47B

P/E Ratio

21.80

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

513M

Total Cash/Share

10.76

Total Debt

11.9M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

512M

P/B Ratio

2.88

Cash Flow

N/A

Earnings

-2.27

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

48K

Current Ratio

36.37

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-109.1M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-22.55

Shares Held By Institutions

1.95B

Shares Outstanding - Current

47.7M

Total Liabilities

23.7M

Total Volume MTD

N/A

Value

-1

Gain YTD

74.352

View a ticker or compare two or three

Compare

RAPP

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for RAPP

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details